Newly identified Type R capillaries crucial for bone remodeling and aging
Throughout our lives, our bones are continuously remodeled to maintain strength, repair injuries and adapt to new stresses.
NAYA Biosciences, Inc.: NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody
PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications • NAYA aiming to initiate clinical trials in early 2026 SARASOTA, Fla.